
iNtRON Biotechnology, Inc. — Investor Relations & Filings
iNtRON Biotechnology, Inc. is a biotechnology company specializing in solutions for infectious diseases. Its core activities are centered on three main pillars: bio-new drugs, molecular diagnostics, and molecular biology reagents. The company's therapeutic pipeline focuses on developing novel treatments for drug-resistant super-bacteria, creating antibiotic alternatives and other bio-active agents to address the challenge of antimicrobial resistance (AMR). In its diagnostics division, iNtRON develops and manufactures detection kits and assays, primarily based on real-time PCR technology, for the rapid identification of infectious organisms. The company also provides a range of molecular reagents for research and has commercialized antibiotic alternative products for the animal health market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 기타경영사항(자율공시)(전환우선주의 보통주 전환청구) | 2020-08-28 | Korean | |
| [연장결정]주요사항보고서(자기주식취득신탁계약체결결정) | 2020-08-28 | Korean | |
| 반기보고서 (2020.06) | 2020-08-14 | Korean | |
| 영업(잠정)실적(공정공시) | 2020-08-04 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2020-07-01 | Korean | |
| [연장결정]주요사항보고서(자기주식취득신탁계약체결결정) | 2020-06-26 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 9465773 | 기타경영사항(자율공시)(전환우선주의 보통주 전환청구) | 2020-08-28 | Korean | ||
| 9465743 | [연장결정]주요사항보고서(자기주식취득신탁계약체결결정) | 2020-08-28 | Korean | ||
| 9482083 | 반기보고서 (2020.06) | 2020-08-14 | Korean | ||
| 9505664 | 영업(잠정)실적(공정공시) | 2020-08-04 | Korean | ||
| 9526299 | 주식등의대량보유상황보고서(약식) | 2020-07-01 | Korean | ||
| 9529240 | [연장결정]주요사항보고서(자기주식취득신탁계약체결결정) | 2020-06-26 | Korean | ||
| 9533735 | 기타경영사항(특허권취득)(자율공시)(신규한 엔테로박터 애로진스 박테리오파지 Ent-AEP-1 및 이의 엔테로박터 애로진스 균과 엔테로박터 클로아카 균 증식 억제 용도) | 2020-06-22 | Korean | ||
| 9535862 | 투자판단관련주요경영사항(슈퍼박테리아 바이오신약 N-Rephasin SAL200의 임상1b상 시험 결과보고서 수령) | 2020-06-18 | Korean | ||
| 9542311 | 기타경영사항(자율공시)(전환우선주의 보통주 전환청구) | 2020-06-09 | Korean | ||
| 9548220 | 단일판매ㆍ공급계약체결 | 2020-06-01 | Korean | ||
| 9548218 | 단일판매ㆍ공급계약체결 | 2020-06-01 | Korean | ||
| 9549935 | 주식등의대량보유상황보고서(일반) | 2020-05-29 | Korean | ||
| 9549845 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2020-05-29 | Korean | ||
| 9549670 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2020-05-29 | Korean | ||
| 9556648 | [기재정정]분기보고서 (2020.03) | 2020-05-21 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
iNtRON Biotechnology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16429/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16429 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16429 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16429 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16429}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for iNtRON Biotechnology, Inc. (id: 16429)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.